Grace Therapeutics, Inc. (GRCE) vs Rockwell Medical, Inc. (RMTI)
A side-by-side comparison of Grace Therapeutics, Inc. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GRCE
Grace Therapeutics, Inc.
$2.13HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
RMTI
Rockwell Medical, Inc.
$8.18HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
Total return — GRCE vs RMTI
growth of $100 · dividends reinvested · last 2yGRCE -31.6% (-17.3%/yr)RMTI -79.3% (-54.5%/yr)GRCE compounded faster over this window
GRCE RMTI
GRCE vs RMTI: by the numbers
- •GRCE is the larger company ($35M vs $32M market cap).
- •Both run net losses; GRCE's is the smaller (0.00% vs -7.33% net margin).
Metrics side by side
Valuation
| Metric | GRCE | RMTI |
|---|---|---|
| P/S ratio | N/A | 0.47 |
| P/B ratio | 0.72 | 0.92 |
| FCF yield | N/A | 4.77% |
Profitability
| Metric | GRCE | RMTI |
|---|---|---|
| Gross margin | 0.00% | 17.71% |
| Operating margin | 0.00% | -6.52% |
| Net margin | 0.00% | -7.33% |
| ROE | -44.50% | -14.49% |
| ROIC | -52.61% | -9.60% |
Growth (annualized)
| Metric | GRCE | RMTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.59% |
| Total return CAGR (5Y) | N/A | -33.38% |
Go deeper
Dig into the metrics
Grace Therapeutics ROERockwell Medical ROEGrace Therapeutics operating marginRockwell Medical operating marginGrace Therapeutics revenue growthRockwell Medical revenue growthGrace Therapeutics free cash flowRockwell Medical free cash flow
Grace Therapeutics & Rockwell Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.